All Topics

On June 3, 2026, the U.S. Food and Drug Administration issued a new draft guidance titled Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities — Questions and Answers (the 2026 Draft Payor Guidance).

A U.S. importer of industrial dehumidifiers came under CBP scrutiny following a site visit by an import specialist who took the position that a higher-duty classification applied. CBP rate-advanced entries, required the importer to adopt the new classification immediately, and threatened penalty exposure requiring a prior disclosure.

The SEC rescinded Rule 202.5(e), which had codified the SEC rule requiring settling parties to agree that they would not publicly deny the SEC’s allegations. The change brings the SEC in line with the majority of federal agencies, including the CFTC which announced a similar change in early June. New language reflecting the change is already appearing in SEC orders.